TAMA is a multi-system immune; T-cell mediated disorder with liver, skin and intestinal inflammation similar to GVHD on a background of malignant thymoma. We describe a case of TAMA with symptoms, signs and serology suggestive of SLE
A 44-year-old woman was admitted to hospital with a 6-month history of weight loss and profuse watery diarrhoea. She reported intermittent oral ulceration, lethargy, appetite loss, night sweats, fevers, cough and shortness of breath. There was no history of dysphagia, skin or eye complaints, joint problems or vaginal ulceration.
The patient had been diagnosed with metastatic thymoma in 2005 but was in remission one year later after neo-adjuvant chemotherapy and surgical resection. Medical comorbidities included hypertension and diet-controlled Type II Diabetes Mellitus. There was no family history of any rheumatic disorders.
At presentation she was unwell, jaundiced with lymphadenopathy and a generalised erythroderma-like maculopapular, non-blanching rash. Abdominal examination revealed right upper quadrant tenderness. There was left-sided meralgia paraesthetica and a symmetrical lower limb sensory peripheral neuropathy.
Laboratory Microbiological studies excluded any significant infection. These findings with the multi-organ clinical presentation raised the possibility of SLE as the underlying diagnosis; however the findings on skin, colonic and liver biopsies were suggestive of graft versus host disease which constitutes epidermal necrosis with lymphocytic infiltration and keratinocyte apoptosis. These findings with the previous history of thymoma were diagnostic for the phenomenon of thymoma-associated autoimmunity (TAMA).
The patient was treated with intravenous methylprednisolone (500 mg for 5 days) then oral prednisolone 1 mg/kg (60 mg) with subsequent improvement in liver function, and then commenced on mycophenolate (1.5 g bd) and intravenous immunoglobulin (0.4 g/kg). During her admission, the patient's condition was further complicated by recurrent chest infections, Methicillin-Resistant Staphylococcus aureus (MRSA) colonisation and Clostridium difficile diarrhoea. The patient subsequently died from overwhelming sepsis.
Discussion
TAMA was first proposed in 2007 by Wadhera et al. 1 and is defined as an inflammatory disorder of the liver, intestine or skin with histological features similar to that of GVHD in the presence of a malignant thymoma, but in the absence of haematopoietic stem cell transplantation. Up to 85 cases have been reported in a 6-year period. Thymic malignancies are rare (less than 0.13 cases per 100 000) .Thymoma accounts for one fifth of all anterior mediastinal tumours and the most common presentations are of paraneoplastic syndromes, followed by compressive lesions affecting the respiratory tract or other anterior mediastinal structures. 3, 4 Given the role of the thymus in the induction and maintenance of self-tolerance, any abnormality in its function has the potential for autoimmune disease which is diagnosed in one-third of patients with thymoma. These are listed in Table 1 . Numerous theories have been postulated to explain the mechanisms by which thymoma induces auto reactivity: thymic destruction by tumour-growth will result in thymic dysfunction leading to impaired self-tolerance, T-cell immaturity, and increased thymocyte proliferation resulting in cellular and humoral immune dysregulation. 3 The prevalence of SLE in patients with thymoma may range from 2 to 10% and it is proposed that an underlying thymoma should be considered in those patients aged over 50 with newly diagnosed SLE. 5 ds-DNA has specificity of up to 97% and sensitivity of 60% with false positives being related to the assay used and the presence of other autoimmune conditions. The clinical signs and symptoms are key to making the diagnosis. 6 GVHD is a multi-system disorder affecting up to 80% of patients following haematopoietic stem cell transplantation. Patients present with skin, liver and gastro-intestinal disease which ranges from mild to life-threatening. Dermatological features include an exanthematous maculopapular rash affecting the hands, feet and may involve the face, trunk and body. Gastrointestinal disease includes severe secretory diarrhoea and a cholestatic pattern of liver injury. Endoscopic biopsies show patchy ulcerations, apoptotic bodies at crypt bases and flattening of surface epithelium whilst liver biopsies show endothelialitis, portal lymphocytic infiltration, pericholangitis and bile-duct destruction. 7 Skin lesions however are indistinguishable between patients with GHVD and TAMA and contain infiltrate of self-reactive cytotoxic T lymphocytes (CTLs) with a reduction in T regulatory lymphocytes (Tregs). 8 Treatment is defined by organ involvement and severity of disease, which includes corticosteroids, calcineurin receptor blockers (cyclosporine), mycophenelate mofetil anti-TNF therapy, IL2 receptor blockade, and mesenchymal stem cell transplantation. 7, 9 Therapeutic approaches for TAMA are similar to GVHD. Overall TAMA has a bad prognosis with death usually from overwhelming infection.
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